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Summary
Objective: To determine ﬂuoroscopy time (FT) and radiation dose (RD) applied in
percutaneous closure of interatrial septal communications (IAC).
Background: Percutaneous closure of IAC, namely patent foramen ovale (PFO) and
atrial septal defect (ASD) is increasingly performed. In this often young population in
full reproductive age, radiation dosage should be an important issue, yet consistent
data on applied radiation dose have not been available to date.
Methods: A single center observational cohort study in 50 consecutive patients
undergoing closure of a PFO or ASD. RD and FT as recorded by the cardiac catheter
laboratory were determined to be the main outcome measures. Secondary outcome
measures were determined to be major adverse events.
Results: FT averaged 6.3 (±4, 1.4—21.1)min, whereas RD measured as dose area
product averaged 325.5 (±271.1; 11.6—1103.4) dGray× cm2. The latter is equivalent
to an effective dose of 6.5milliSievert (0.24—22mSv).
Conclusion: Whereas closure of IAC can be associated with a low radiation exposure
of 0.24mSv, sometimes appreciably higher doses are applied, mandating more care-
ful consideration of radiation safety issues in this patient population, especially the
subset younger than 45 years. Analogous to data and recommendations published for
radiation dose in coronary angiography, there is a need for binding reference values
which would serve as guide
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nterest in ﬂuoroscopy time (FT) and radiation
osage (RD) applied in diagnosis and percutaneous
ntervention in coronary artery disease (CAD) has
een renewed recently, with ample data being
ublished on the subject [1—3]. Less systematic
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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satient radiation dose during percutaneous interve
nformation is available concerning FT and RD
pplied during interventional closure of interatrial
eptal communications (IAC) namely patent fora-
en ovale (PFO) and atrial septal defect (ASD), but
ublished data of FT by some large-volume cen-
ers are available [4,5]. Because closure of a PFO
r ASD is increasingly performed in younger per-
ons, the issue may be even more relevant than in
atients with CAD. It may therefore be important to
evelop guidelines and reference values, especially
or low-volume operators.
ethods
atient group
his study includes all 50 consecutive patients (26
emales) undergoing PFO or ASD closure by the
uthors. Mean age was 52.8± 15 (24—83) years; 16
atients (32%) were younger than 45 years of age.
our patients (8%) had an ASD, 2 of whom were
symptomatic with a left-right shunt calculated to
e 30%. One patient had a shunt >50% and reported
aving dyspnea; echocardiography showed a sig-
iﬁcantly enlarged right atrium. One patient had
ecurrent atrial ﬁbrillation and a shunt of about
0%. Patient body mass index (BMI) was 25.33± 4.23
19—37.8). All patients with PFO were referred by
neurologist, primarily for a search for cardio-
enic emboli and had either experienced a stroke,
transient ischemic attack, or had signs of vascu-
ar encephalopathy on magnetic resonance imaging
r computed tomography scanning. The search
or cardiogenic emboli included a thorough his-
ory and physical examination, a resting and stress
lectrocardiogram (ECG), a 24-h ECG recording,
transthoracic (TTE) and transesophageal (TEE)
chocardiogram and routine clinical chemistry
ncluding cholesterol levels, a blood cell count, as
ell as a screening for coagulopathies including:
ctivated protein C (APC) resistance, factor V Lei-
en mutation, prothrombin gene mutation, protein
and S, antithrombin III, and lupus anticoagulant.
FO or ASD closure
losure was performed simultaneously under ﬂu-
roscopy (PhilipsTM AD5, Philips Medical Systems,
indhoven, the Netherlands) and echocardiography
Siemens SequoiaTM, Siemens Medical Solutions,
rlangen, Germany); TEE was used during the pro-
edure in 49 patients and intracardiac echocardiog-
aphy (ICE) in 3 patients. 2 g Ceftriaxone was intra-
enously applied before and 6 h after implantation.
re-interventional medication further included an
M
T
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ntiemetic, atropine (to reduce salivation), and
benzodiazepine for sedation. Balloon sizing was
nly performed in the last 6 patients, all patients
ad pre-interventional TEE and defect sizing.
wenty-ﬁve AmplatzerTM (AGA Medical Corp., Ply-
outh, MN, USA), 8 PremereTM (St. Jude Medical,
aple Grove, MN, USA), 14 FigullaTM (Occlutech,
ena, Germany), and 5 SolysafeTM (Swissimplant,
olothurn, Switzerland) devices were used.
ollow-up evaluation
ll patients were scheduled for TTE within 1 month
nd TEE within 6 months after implantation. One
atient skipped the ﬁrst follow-up. In a second
atient, TTE quality was inadequate due to over-
eight.
tatistical analysis
ontinuous variables are expressed as mean (S.D.)
nd were compared by a paired t-test. Signiﬁcance
as assumed at a p-value < 0.05. Regression anal-
sis computed correlation coefﬁcients. Categorical
ariables are reported as counts and percentages.
ll data were analyzed using the StatView® pro-
ram, SAS systemsTM (Cary, NC, USA).
esults
hort-term outcome
n all patients a device could be delivered, except
n a 36-year-old patient with a residual shunt a
ew months after placement of an AmplatzerTM
evice. Although placement of the second device
as straightforward, it was positioned vertically to
he ﬁrst one and protruding in the lumen of both
tria. A better alignment could not be achieved,
ven with a larger device, so that it was decided
o retrieve it. No patient experienced any compli-
ation or side effect during hospitalization. One
atient returned 1 week after device placement
ecause of a painful swelling at the puncture site,
hich showed to be a ﬁstula between the femoral
ein and a side branch of the femoral artery. The
stula was repaired surgically without interruption
f platelet aggregation inhibitors and the patient
as discharged the same day. He has since been
een for follow-up and was asymptomatic.id-term outcome
wo patients (4%) showed residual shunts during
months of follow-up. The ﬁrst, a 38-year-old
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male, patient had a PremereTM device implanted
for a tunnelled PFO and showed a relevant resid-
ual shunt. It was closed successfully using a second
similar device. The second patient (detailed above)
was a saxophone player who had resumed playing
shortly after AmplatzerTM device implantation and
omitted the 1-month TTE. After implantation of a
second device was not successful, he was advised
to undergo a third closure attempt with a different
device or surgery; he chose to wait and continue
on clopidogrel and aspirin. In 1 patient (2%) device
migration was documented and followed by its per-
cutaneous retrieval [6].
Fluoroscopy and radiation dose (RD) data
FT and RD were automatically measured and
printed at the end of each intervention. RD
was measured as dose area product (DAP)
in dGray× cm2. FT averaged 6.3 (±4, range
1.4—21.1)min (Fig. 1). RD averaged 325.5 (±271.1,
range 11.6—1103.4) dGray× cm2 (Fig. 2). Proce-
dure time averaged 54.2 (±19.2, range 30—100)min
(Fig. 1). As was to be expected, there was no corre-
lation between FT and RD (Fig. 3), mainly because
body mass is an important factor inﬂuencing RD.
Figure 1 Procedure and ﬂuoroscopy time in minutes,
n = 50. The horizontal bars denote the 10th, 25th, 50th,
75th, and 90th percentile respectively. Dots denote single
data sets below the 10th or above the 90th percentile.
Figure 2 Radiation dose in dGray× cm2. The horizontal
bars denote the 10th, 25th, 50th, 75th, and 90th per-
centile respectively. Dots denote single data sets below
the 10th or above the 90th percentile.
Figure 3 Correlation between ﬂuoroscopy time in min-
utes and radiation dose in dGray× cm2, r2 = 0.25.
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Table 1 List of patients (n = 12; 24%) having received a radiation dose above the mean value of this series
(326 dGray× cm2).
Patient RD (dGray× cm2) Reason for increased RD
1 1103.42 Unnecessary long FT 12.4min, ﬁrst patient with PremereTM
2 471 None readily apparent, FT 7.6min
3 431.7 Prior diagnostic CA during same procedure, FT 10.6min
4 745.46 Prior diagnostic CA during same procedure, FT 11min
5 366 None readily apparent, FT 5.6min
6 558.3 None readily apparent, FT 8.4min
7 393.3 None readily apparent, FT 6.5min
8 544 None readily apparent, FT 8min
9 953.8 ASD size underestimated by TEE alone, device had to be exchanged twice for right
match after balloon sizing, large patient (98 kg, 165 cm)
10 868.5 Large patient, total FT 1.5min
11 729.19 Attempt at closure of residual shunt, device exchanged twice
12 506 None readily apparent, FT 6.9min
aphy.
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wFT, ﬂuoroscopy time; RD, radiation dose; CA, coronary angiogr
There was no difference between RD deliv-
red to patients over and under 45 years of
ge respectively (362.1± 291; 19.4—1103.4 versus
19.9± 209.4; 11.6—729.2 dGray× cm2; p = 0.174).
here was however a statistically signiﬁcant dif-
erence in FT (7± 4.3; 1.5—21.1min in patients
ged over 45 years versus 4.8± 2.6; 1.4—11.3min
n those under 45 years; p = 0.0211). Data of all
atients that received a RD above the mean of this
eries were examined to try to determine the cause
f the delivered excess dosage or time needed
Table 1).
Twelve patients (24%) were exposed to more than
he 50th percentile of the RD of 326 dGray× cm2.
n 2 patients, this was partly due to the coronary
ngiography (CA) performed prior to IAS closure. In
patient, the defect had been undersized by TEE.
his was detected by inadequate positioning of the
evice before release, followed by retrieval, sizing
alloon measurement, and placement of an ade-
uate device. In 1 patient described above (Fig. 1),
he prolonged FT resulted from an attempt of clo-
ure of a residual shunt with two devices. In 1 large
atient (BMI 33.3), a large RD was applied, in spite
f a FT of only 1.5min. The maximal deviation in RD
as 1103.4 dGray× cm2, in whom the only expla-
ation for the FT of 12.4min was that it was the
rst time a PremereTM device was implanted. In
he other 6 patients no obvious cause for prolonged
T was found. The longest FT of 21.1min occurred
n 1 of the patients in which CA was necessary,
nd which had very tortuous and kinked pelvic ves-
els, entailing insertion of a long arterial sheath and
anipulation to get to the coronary ostia. In this
eries of 50 patients, CA was performed before IAC
n 4 patients.
d
t
i
e
wProcedure time ranged from 30 to 100min,
ith a mean of 54.2± 19.2min. Some of the
onger procedure times resulted from, having to
ait (sometimes for as long as 45min) for the
ardiologist performing TEE (MR), the latter not
eing dedicated to the cardiac catheterization
aboratory, sometimes experiencing unexpected
ntraoperative and other delays.
iscussion
he ﬂuoroscopy times in this series compare favor-
bly with those reported by larger centers with
eans of 8.3min [5] and 9.5min for TEE and 6min
or ICE [4], although the latter institutions may now
e able to report lower values with increasing expe-
ience. No data on RD are available, to the best of
ur knowledge.
Radiation is measured as DAP and not as effec-
ive dose (ED), the latter being the more relevant
nit for assessing both the deterministic as well
s the stochastic radiotoxicity risk. Although a
onversion factor may be applied to compute
he ED [2], the process remains approximative at
est.
In certain cases, it is possible to reduce
AP to below 20 dGray× cm2, amounting to an
D of 0.4milliSievert (mSv). The mean DAP is
26 dGray× cm2, yielding an average ED of 6.6mSv,
hich is more or less equal to that needed for a
iagnostic CA (including ventriculography and aor-
ography) and less than that of an average coronary
ntervention [1—3]. Some patients received higher
ffective doses (Table 1), amounting to 22mSv,
hich is obviously less desirable.
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In the patient with the residual shunt treated by
another PremereTM device, almost identical FT was
needed. The ﬁrst intervention was performed with
the usual frame rate for CA of 15 frames/s, while
for the second attempt, the frame rate was set
at 3.75 frames/s. The reduction in DAP was dras-
tic, from 558.8 to 197.4 dGray× cm2, whereas FT
was unchanged 8.4min versus 8.3min. This ﬁnding
underlines the fact that, while it is imperative to
try to keep FT as low as possible, other factors may
be equally important in reducing RD and have to be
borne in mind.
Obviously this is an observational, single center
study. But there is more to the ﬁndings than just the
fact that a low-volume operator does not undercut
a large-volume institution in terms of FT, procedure
time, and RD.
Interventional cardiologists should be committed
to the concept that minimizing RD in the younger
patient population undergoing closure of an IAC
has highest priority and precedes considerations
of comfort (avoiding TEE) [7]. ICE is an attractive
alternative, but its application is limited by its pro-
hibitive price.
For us, sole echocardiography guidance without
ﬂuoroscopy [8] is no alternative for ASD and PFO
closure. Most interventional cardiologists would
use ﬂuoroscopy anyway after venous puncture and
while inserting the catheter and guide wire to
the right atrium, as well as when pushing the
sheath across the IAC. After realization that pre-
interventional TEE may not always adequately
assess defect size, sometimes grossly underestimat-
ing it, we returned to balloon sizing of every defect
including PFOs, despite reports describing septum
laceration during sizing [9].
Estimation of organ radiation dose applied dur-
ing the procedure, especially the female breast
and gonads, to our knowledge only be extrap-
olated from available CA data [10], the latter
coming nearest to closure of IASD in terms of
radiation type applied. Weighted organ equivalent
doses, as documented for cardiac radionuclide and
computed tomography studies [1] are yet to be
provided. Although a linear extrapolation cannot
be expected, an average of two- to three-fold
breast, ovaries, and testicle dose compared to CA
[10] may have to be expected, yielding 14—21mSv
for the breasts, 2.2—3.3mSv for the ovaries, and
1—1.5mSv for the testicles respectively.
To limit RD, we have lately begun to proceed as
follows: if crossing the IAC under ﬂuoroscopy is not
successful within 90 s, further crossing attempts are
continued only after the TEE is in place and the
interatrial septum is visualized. Cine angiography
frame rate will be set at the lowest possible min-P. Wagdi, M. Ritter
mum of 3.75 frames/s, compared to the default
5—30 frames/s. Frame rate is only increased if
mage quality is insufﬁcient due to overweight or
f CA is concomitantly needed. For ﬂuoroscopy,
arameters such as frame rate and delivered energy
annot be operator-modiﬁed in the angiography
quipment used. These parameters are set by
efault once patient weight and height are entered.
gonadal protection is applied to all female
atients of childbearing age and to all males under
0 years of age. We never perform closure of an
ASD in a pregnant patient, even if the gestation is
eyond the 4th month of conception.
It is certainly not up to a low-volume operator
o recommend FT and RD ﬁgures for closure of IAC.
he high-volume centers are invited to publish their
ata and work out binding reference values which
hould serve guidelines as for all interventional car-
iologists involved.
cknowledgments
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